发明名称 Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant
摘要 Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application.
申请公布号 US2014276482(A1) 申请公布日期 2014.09.18
申请号 US201414212817 申请日期 2014.03.14
申请人 ForSight Vision4, Inc. 发明人 Astafieva Irina;Horvath Judit;Farinas Kathleen Cogan;Bueche Blaine;Erickson Signe
分类号 A61K31/506;A61K31/444;A61K31/416;A61K31/404;A61K31/4439 主分类号 A61K31/506
代理机构 代理人
主权项 1. A therapeutic agent delivery system comprising a therapeutic device having a reservoir chamber coupled to a porous structure for controlled release of a therapeutic agent in the vitreous of the eye and a formulation comprising a therapeutic agent and one or more formulation agents, wherein the formulation is contained in the reservoir of the therapeutic device; and the controlled release of the therapeutic agent and formulation agents from the reservoir through the porous structure increases the half-life of the therapeutic agent in the vitreous.
地址 Menlo Park CA US